| CTRI Number |
CTRI/2024/03/063657 [Registered on: 06/03/2024] Trial Registered Prospectively |
| Last Modified On: |
04/03/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [hair oil] |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A study to check hair growth benefits |
|
Scientific Title of Study
|
To evaluate the safety and efficacy of the test products in comparison to baseline in improving hair growth rate and reducing hair fall among healthy subjects |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| HAIR/MAHS/2024-01, version 1.0 dated 22 Feb 2024 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Mukesh Ramnane |
| Designation |
Principal Investigator |
| Affiliation |
MS Clinical Research |
| Address |
Room no. 1, Second floor
Hair department
327/15, 1st Main Road
Cambridge layout, Ulsoor
Bangalore KARNATAKA 560008 India |
| Phone |
08041125934 |
| Fax |
08040917253 |
| Email |
mukesh.ramnane@msclinical.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Mukesh Ramnane |
| Designation |
Principal Investigator |
| Affiliation |
MS Clinical Research |
| Address |
Room no. 1, Second floor
Hair department
327/15, 1st Main Road
Cambridge layout, Ulsoor
Bangalore KARNATAKA 560008 India |
| Phone |
08041125934 |
| Fax |
08040917253 |
| Email |
mukesh.ramnane@msclinical.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Mukesh Ramnane |
| Designation |
Principal Investigator |
| Affiliation |
MS Clinical Research |
| Address |
Room no. 1, Second floor
Hair department
327/15, 1st Main Road
Cambridge layout, Ulsoor
Bangalore KARNATAKA 560008 India |
| Phone |
08041125934 |
| Fax |
08040917253 |
| Email |
mukesh.ramnane@msclinical.com |
|
|
Source of Monetary or Material Support
|
| Marico Limited,
MARKS, plot no:23-C
Mahakalli Caves Road
Andheri (E)
Mumbai-400093 |
|
|
Primary Sponsor
|
| Name |
Marico Limited |
| Address |
MARKS, plot no:23-C Mahakalli Caves Road Andheri (E)
Mumbai-400093 |
| Type of Sponsor |
Other [FMCG (Fast moving Consumer Goods)] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mukesh Ramnane |
MS Clinical Research Pvt. Ltd |
Room no. 1, Second floor
Hair department
327/15, 1st Main Road
Cambridge layout, Ulsoor Bangalore KARNATAKA |
08041125934
mukesh.ramnane@msclinical.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Clinicom |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Healthy male and female subjects |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
FM-9 Hair oil |
Apply the required quantity while making small partition across the scalp. Start from front and move to the back for uniform application
Leave the oil for 30 minutes or overnight (as per consumer regular habit) and wash the next day with the provided shampoo. |
| Comparator Agent |
Not applicable |
Not Applicable |
| Intervention |
XW-1 Hair oil |
Apply the required quantity while making small partition across the scalp. Start from front and move to the back for uniform application
Leave the oil for 30 minutes or overnight (as per consumer regular habit) and wash the next day with the provided shampoo. |
| Intervention |
ZT-6 Hair oil |
Apply the required quantity while making small partition across the scalp. Start from front and move to the back for uniform application
Leave the oil for 30 minutes or overnight (as per consumer regular habit) and wash the next day with the provided shampoo. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
1. Male and female subjects in general good health.
2. Subjects in the age group 18-50 years (both the ages inclusive).
3. Subjects complaining of hair fall and damage.
4. Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol.
5. Hair density of greater than 100 and less than 200 hair follicle per square cm as per TrichoScan measurement
6. Male and female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).
|
|
| ExclusionCriteria |
| Details |
1 Subjects who have undergone any kind of hair growth treatment in the last 3 months
2 Subjects having any active but controllable scalp disease which may interfere in the study assessments
3 Subjects who have taken chemotherapy for cancer in the 6 months prior to the studys start
4 Subjects who have history of crash dieting and or psychiatric disorder including trichotillomania
5 Subjects who have undergone hair transplant
6 A known history or present condition of allergic response or hypersensitivity to any topical or oral cosmetic pharmaceutical or nutraceutical product
7 Subjects on oral medications like topical or systemic corticosteroids undergoing any chemical hair salon treatment which will compromise the study
8 Subjects with chronic illness which may influence the cutaneous state
9 Subjects who are pregnant or nursing Self declared
10 Subjects with any history or present of underlying uncontrolled medical illness or any other serious medical illness |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
• Reduction in hair fall by comb test
• Improvement in hair growth rate, hair thickness, hair density by TrichoScan and dermatological assessments
• Change in anagen and telogen ratio by TrichoScan |
at Baseline, Week 2, Week 4, Week 8, Week 12 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
• Change in hair thinning by dermatologists
• Overall safety of test product
• Change in density of vellus hair & terminal hair |
at Baseline, Week 2, Week 4, Week 8, Week 12 |
|
|
Target Sample Size
|
Total Sample Size="99" Sample Size from India="99"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
14/03/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study is designed to investigate the effectiveness and safety of a new product related to hair growth. It will be conducted in a single location, with a double-blinded, randomized approach. The study will last for 12 weeks, involving 10 visits for participants. The first two visits focus on screening, randomization, and baseline assessments. Subsequent visits include shaving and assessment, along with follow-up assessments at different time points. Participants will be divided into three test groups, and after the initial 4 weeks, only two of these groups will continue with the study. Various assessments, including TrichoScan® (a method for hair assessment), will be conducted throughout the study. Participants will be instructed to discontinue any other hair care medications during the study, and they will receive the assigned test product along with a neutral shampoo. Regular follow-up visits will assess the participants’ progress, and those who discontinue the study will sign an exit form. The study aims to gather information on the effects of the test product on hair growth. |